quantisnow
FeedTopReportsPricing
⌘K
Live feed
17:37:18·848d
INSIDERFiling
POINT Biopharma Global Inc. logo

Lubner David Charles returned 3,600 shares to the company, closing all direct ownership in the company (SEC Form 4)

PNT· POINT Biopharma Global Inc.
Health Care
Original source

Companies

  • PNT
    POINT Biopharma Global Inc.
    Health Care

Recent analyst ratings

  • Jul 20UpdateJefferies$14.00
  • Dec 14UpdateRaymond James$10.00
  • Nov 30UpdateSVB Leerink$14.00
  • Oct 11UpdateOppenheimer$20.00
  • Sep 16UpdateTruist$22.00
  • Sep 14UpdateBerenberg$20.00

Related

  • PR695d
    Delcath Systems Announces Appointment of Bridget Martell, MA, MD to Delcath's Board of Directors
  • SEC836d
    SEC Form 15-12G filed by POINT Biopharma Global Inc.
  • SEC842d
    SEC Form EFFECT filed by POINT Biopharma Global Inc.
  • SEC842d
    SEC Form EFFECT filed by POINT Biopharma Global Inc.
  • INSIDER848d
    SEC Form 4 filed by Goodman Jonathan R.
  • INSIDER848d
    SEC Form 4 filed by Kelly Justyna
  • INSIDER848d
    Mccann Joe A. closing all direct ownership in the company (SEC Form 4)
  • INSIDER848d
    SEC Form 4 filed by Jensen Jessica D.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022